Loading data
MYNDNYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 167.93 m USD | 267.38 m USD | 411.76 m USD | 584.68 m USD | 448.19 m USD |
| Cost of revenue | 132.64 m USD | 201.14 m USD | 311.27 m USD | 443.6 m USD | 309.22 m USD |
| Gross profit | 35.29 m USD | 66.24 m USD | 100.49 m USD | 141.09 m USD | 138.97 m USD |
| Research and development expense | 12.83 m USD | 25.25 m USD | 34.6 m USD | 41.46 m USD | 35.59 m USD |
| Operating profit | -50.1 m USD | -38.04 m USD | -46.04 m USD | 3.43 m USD | 11.07 m USD |
| Interest expense | — | — | 4.66 m USD | 1.83 m USD | 173 k USD |
| Profit before tax | -54.46 m USD | -35.75 m USD | -48.45 m USD | 7.12 m USD | 8.65 m USD |
| Income tax expense | -384 k USD | 68.73 m USD | -9.66 m USD | -25.98 m USD | 1.79 m USD |
| Net income (reported basis) | -54.07 m USD | -95.72 m USD | -39.43 m USD | 20.46 m USD | -1.1 m USD |
| Net income attributable to common shareholders | -54.07 m USD | -95.72 m USD | -39.43 m USD | 20.46 m USD | -1.1 m USD |
| Basic earnings per share | -0.12 USD/share | -0.21 USD/share | -0.09 USD/share | 0.05 USD/share | 0 USD/share |
| Diluted earnings per share | -0.12 USD/share | -0.21 USD/share | -0.09 USD/share | 0.05 USD/share | 0 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.